<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="2.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JFR</journal-id>
      <journal-id journal-id-type="nlm-ta">JMIR Form Res</journal-id>
      <journal-title>JMIR Formative Research</journal-title>
      <issn pub-type="epub">2561-326X</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v7i1e37293</article-id>
      <article-id pub-id-type="pmid">36705963</article-id>
      <article-id pub-id-type="doi">10.2196/37293</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Mobile Health App (ChillTime) Promoting Emotion Regulation in Dual Disorders: Acceptability and Feasibility Pilot Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Mavragani</surname>
            <given-names>Amaryllis</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Campbell</surname>
            <given-names>Aimee</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Barrigon</surname>
            <given-names>Maria Luisa</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author">
          <name name-style="western">
            <surname>Pennou</surname>
            <given-names>Antoine</given-names>
          </name>
          <degrees>BA</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-2076-5559</ext-link>
        </contrib>
        <contrib id="contrib2" contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Lecomte</surname>
            <given-names>Tania</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <address>
            <institution>Département de Psychologie</institution>
            <institution>Université de Montréal</institution>
            <addr-line>90 Avenue Vincent d’Indy</addr-line>
            <addr-line>Bur. C-358, Pavillon Marie-Victorin, succ Centre-Ville, post office box 6128</addr-line>
            <addr-line>Montreal, QC, H2C 3J7</addr-line>
            <country>Canada</country>
            <phone>1 514 343 6274</phone>
            <email>tania.lecomte@umontreal.ca</email>
          </address>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-0340-3759</ext-link>
        </contrib>
        <contrib id="contrib3" contrib-type="author">
          <name name-style="western">
            <surname>Potvin</surname>
            <given-names>Stéphane</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-1624-378X</ext-link>
        </contrib>
        <contrib id="contrib4" contrib-type="author">
          <name name-style="western">
            <surname>Riopel</surname>
            <given-names>Gabrielle</given-names>
          </name>
          <degrees>BA</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-0290-0195</ext-link>
        </contrib>
        <contrib id="contrib5" contrib-type="author">
          <name name-style="western">
            <surname>Vézina</surname>
            <given-names>Camille</given-names>
          </name>
          <degrees>BA</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-2123-2949</ext-link>
        </contrib>
        <contrib id="contrib6" contrib-type="author">
          <name name-style="western">
            <surname>Villeneuve</surname>
            <given-names>Marie</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-0248-1181</ext-link>
        </contrib>
        <contrib id="contrib7" contrib-type="author">
          <name name-style="western">
            <surname>Abdel-Baki</surname>
            <given-names>Amal</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-3333-9652</ext-link>
        </contrib>
        <contrib id="contrib8" contrib-type="author">
          <name name-style="western">
            <surname>Khazaal</surname>
            <given-names>Yasser</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-8549-6599</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>Département de Psychologie</institution>
        <institution>Université de Montréal</institution>
        <addr-line>Montreal, QC</addr-line>
        <country>Canada</country>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution>Centre de Recherche de l'Institut Universitaire en Santé Mentale de Montréal</institution>
        <addr-line>Montreal, QC</addr-line>
        <country>Canada</country>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution>Centre Hospitalier de l’Université de Montréal</institution>
        <addr-line>Montreal, QC</addr-line>
        <country>Canada</country>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution>Département de Psychiatrie</institution>
        <institution>Université de Montréal</institution>
        <addr-line>Montreal, QC</addr-line>
        <country>Canada</country>
      </aff>
      <author-notes>
        <corresp>Corresponding Author: Tania Lecomte <email>tania.lecomte@umontreal.ca</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>1</month>
        <year>2023</year>
      </pub-date>
      <volume>7</volume>
      <elocation-id>e37293</elocation-id>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>3</month>
          <year>2022</year>
        </date>
        <date date-type="rev-request">
          <day>22</day>
          <month>8</month>
          <year>2022</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>12</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </history>
      <copyright-statement>©Antoine Pennou, Tania Lecomte, Stéphane Potvin, Gabrielle Riopel, Camille Vézina, Marie Villeneuve, Amal Abdel-Baki, Yasser Khazaal. Originally published in JMIR Formative Research (https://formative.jmir.org), 27.01.2023.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://formative.jmir.org/2023/1/e37293" xlink:type="simple"/>
      <abstract>
        <sec sec-type="background">
          <title>Background</title>
          <p>A growing number of studies highlight the importance of emotion regulation in the treatment and recovery of individuals with psychosis and concomitant disorders such as substance use disorder (SUD), for whom access to integrated dual-disorder treatments is particularly difficult. In this context, dedicated smartphone apps may be useful tools to provide immediate support to individuals in need. However, few studies to date have focused on the development and assessment of apps aimed at promoting emotional regulation for people with psychosis.</p>
        </sec>
        <sec sec-type="objective">
          <title>Objective</title>
          <p>The aim of this study was to evaluate the feasibility, acceptability, and potential clinical impact of a dedicated app (ChillTime) for individuals with psychotic disorders and concurrent SUD. The app design process followed recommendations for reducing cognitive effort on a mobile app. A total of 20 coping strategies regrouped in four categories (behavioral, emotional, cognitive, spiritual) were included in the app.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>This open pilot study followed a pre-post design. After the initial assessment, researchers asked participants to use the app as part of their treatment over a 30-day period. Feasibility was determined by the frequency of use of the app and measured using the number of <italic>completed</italic> strategies. Acceptability was determined by measuring ease of use, ease of learning, satisfaction, and perceived utility at the end of the 30-day study period based on responses to satisfaction questionnaires. Clinical scales measuring emotion regulation, substance use (ie, type of substance, amount taken, and frequency of use), and various psychiatric symptoms were administered at the beginning and end of the 30-day period.</p>
        </sec>
        <sec sec-type="results">
          <title>Results</title>
          <p>A total of 13 participants were recruited from two first-episode psychosis clinics in Montreal, Quebec, Canada. All participants were symptomatically stable, were between 18 and 35 years of age (mostly men; 70% of the sample), and had a schizophrenia spectrum disorder with a comorbid substance use diagnosis. A total of 11 participants completed the study (attrition&#60;20%). Approximately half of the participants used the tool at least 33% of the days (11-21 days). Cognitive and emotion-focused techniques were rated the highest in terms of usefulness and were the most frequently used. The majority of participants gave positive answers about the ease of use and the ease of learning the tool. A nonsignificant association of ChillTime use with negative symptoms and drug use was observed. No other statistically significant changes were observed.</p>
        </sec>
        <sec sec-type="conclusions">
          <title>Conclusions</title>
          <p>The ChillTime app showed good feasibility (approximately half of the participants used the tool at least 33% of the days) and acceptability among people with schizophrenia spectrum disorder and SUD. Trends suggesting a potential impact on certain clinical outcomes will need to be replicated in larger-sample studies before any conclusion can be drawn.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>dual disorder</kwd>
        <kwd>concomitant disorder</kwd>
        <kwd>mental disorder</kwd>
        <kwd>mental illness</kwd>
        <kwd>satisfaction</kwd>
        <kwd>mobile app</kwd>
        <kwd>mHealth</kwd>
        <kwd>mobile health</kwd>
        <kwd>emotion regulation</kwd>
        <kwd>distress management</kwd>
        <kwd>substance use disorder</kwd>
        <kwd>substance use</kwd>
        <kwd>emotion</kwd>
        <kwd>distress</kwd>
        <kwd>mental health</kwd>
        <kwd>acceptability</kwd>
        <kwd>feasibility</kwd>
        <kwd>psychosis</kwd>
        <kwd>psychotic</kwd>
        <kwd>schizophrenia</kwd>
        <kwd>emotional health</kwd>
        <kwd>pilot study</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction">
      <title>Introduction</title>
      <p>Difficulties in emotion regulation have been documented in psychosis [<xref ref-type="bibr" rid="ref1">1</xref>-<xref ref-type="bibr" rid="ref5">5</xref>] and its most frequent concurrent disorders such as substance use disorder (SUD) [<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref9">9</xref>], depression [<xref ref-type="bibr" rid="ref10">10</xref>-<xref ref-type="bibr" rid="ref12">12</xref>], trauma-related issues [<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref14">14</xref>], and borderline personality disorder [<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref>]. Emotion regulation skills can significantly impact clinical and social recovery [<xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref18">18</xref>]. Emotion regulation difficulties may alter the management of distress associated with hallucinations [<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref>] or other psychotic symptoms [<xref ref-type="bibr" rid="ref21">21</xref>], and can be associated with increased relapse rates [<xref ref-type="bibr" rid="ref22">22</xref>]. Distress management skills have also been associated with social functioning and cognitive difficulties such as processing speed and working memory [<xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref24">24</xref>]. Among factors that may explain these difficulties, some studies have reported that people with psychosis tend to use inefficient emotion regulation strategies [<xref ref-type="bibr" rid="ref5">5</xref>]. A recent systematic review reported that patients with psychosis tended to more frequently use nonadaptive emotion regulation strategies such as suppression, rumination, and self-blame rather than effective strategies such as distraction and cognitive reappraisal compared to healthy controls [<xref ref-type="bibr" rid="ref25">25</xref>]. This review also reported an association between nonadaptive emotion regulation strategies and positive symptoms. Furthermore, emotion regulation difficulties are known to be more pronounced in patients with a concurrent SUD [<xref ref-type="bibr" rid="ref26">26</xref>], a comorbidity frequently encountered in psychosis-related disorders, which is present in approximately 50% of individuals with psychosis [<xref ref-type="bibr" rid="ref27">27</xref>-<xref ref-type="bibr" rid="ref32">32</xref>]. One of the explanations put forward for this phenomenon is that substances are often used as a coping strategy to self-regulate dysphoria and negative emotions [<xref ref-type="bibr" rid="ref26">26</xref>]. Interventions aimed at improving emotional regulation skills could potentially reduce distress associated with psychotic disorders and their comorbidities.</p>
      <p>Global access to mental health treatment is known to be problematic in many settings, even in developed countries [<xref ref-type="bibr" rid="ref33">33</xref>]. This reality is even more pervasive among individuals with SUD [<xref ref-type="bibr" rid="ref34">34</xref>] and psychosis [<xref ref-type="bibr" rid="ref35">35</xref>]. In this context, individuals with concurrent psychosis and SUD face several difficulties in seeking treatment and very few settings offer integrated treatment for their comorbidities [<xref ref-type="bibr" rid="ref36">36</xref>]. This situation has the effect that individuals with concurrent disorders, also called dual disorders, are often either not eligible for specialized treatments targeting one issue at a time or find themselves put on long wait lists in the few centers that can offer integrated treatment. Furthermore, access to interventions targeting emotional regulation interventions is even scarcer.</p>
      <p>The development of mental health apps has grown rapidly in recent years [<xref ref-type="bibr" rid="ref37">37</xref>]. This intervention format offers several advantages for the user (eg, obtaining services anonymously, easy and timely accessibility, no need for transportation, receiving the service at the moment it is needed), as well as for the mental health practitioner or researcher (eg, better ecological validity of the phenomena measured, elimination of memory bias, augmenting therapy by real-life training) and health system (ie, offering potentially easier access to treatment) [<xref ref-type="bibr" rid="ref18">18</xref>]. Interest for these tools has also been observed among patients with psychosis who have expressed interest in the implementation of mental health care apps in conjunction with their usual treatment [<xref ref-type="bibr" rid="ref38">38</xref>]. Recent reviews have illustrated that few validated mobile mental health apps were available for people with psychosis and those with commonly associated comorbidities [<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref37">37</xref>]. Recent research on mental health apps for psychosis have focused on evaluating whether the implementation of apps is well received by patients. Studies have reported a good level of acceptability and feasibility of apps aimed at collecting clinical data in natural environments using an ecological momentary assessment approach [<xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref>] and tools aimed at intervening on certain specific problems such as loneliness [<xref ref-type="bibr" rid="ref41">41</xref>] or consolidation of skills taught in therapy [<xref ref-type="bibr" rid="ref42">42</xref>]. Other apps have also been associated with a decrease in relapse rates, hospitalization, and improved treatment adherence [<xref ref-type="bibr" rid="ref43">43</xref>,<xref ref-type="bibr" rid="ref44">44</xref>]. Conversely, recent data show that some mobile apps could potentially aggravate paranoid thoughts and that some individuals would be more reluctant to use this type of tool in connection with such thoughts [<xref ref-type="bibr" rid="ref45">45</xref>,<xref ref-type="bibr" rid="ref46">46</xref>].</p>
      <p>Despite a significant increase in the number of mobile apps in the mental health field, only a paucity of studies have focused on the validation of apps aimed at improving emotional regulation or coping skills [<xref ref-type="bibr" rid="ref47">47</xref>]. Furthermore, even fewer apps have been adapted specifically for individuals with cognitive deficits such as those seen in psychosis, which greatly limits the availability of tools available to this population [<xref ref-type="bibr" rid="ref48">48</xref>]. To our knowledge, no mobile app for emotional regulation has been adapted and made available for individuals with psychosis. Knowing that individuals with psychosis and SUD face major difficulties in accessing treatment [<xref ref-type="bibr" rid="ref18">18</xref>], we aimed to develop an app adapted to this population that would include the best adaptive emotional regulation strategies reported in the literature. Here, we first describe the steps of app development, followed by presentation of a pilot study aiming to evaluate its feasibility, acceptability, and potential clinical impacts in individuals with psychotic disorders and concurrent SUD.</p>
      <p>The overall aim of this study was to first describe the rationale and development of a mobile app (ChillTime) aiming to provide assistance to people with a dual diagnosis of psychosis and SUD who are currently engaged in outpatient rehabilitation after a first psychosis episode. Second, this study aimed to evaluate the feasibility, acceptability, and potential impact of this smartphone app intervention aiming to promote better emotional regulation for psychological distress in individuals with psychotic disorder and concurrent SUD treated in an outpatient setting in the greater Montreal (Quebec, Canada) area.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>ChillTime App</title>
        <sec>
          <title>App Design and Construction</title>
          <p>The app design process followed Rotondi et al’s [<xref ref-type="bibr" rid="ref48">48</xref>] recommendations for reducing cognitive effort on a mobile app. It uses simple, short, and concrete language and presentations across all sections. All navigation interfaces were designed with the same presentation template to decrease confusion and facilitate navigation. The background and item color themes were all standardized, without adding distractors. All text and audio are in French. We also limited the number of pages to go through to access an exercise (two “clicks” maximum) and the number of categories per page to facilitate navigation.</p>
          <p>Because we wanted the tool to be accessible in as many contexts as possible, it was designed to be accessible when the user would not have access to an internet connection. The last point could be of particular interest for people with low income or for people who are not within the range of a Wi-Fi connection to use the app without using their data.</p>
          <p>Visuals (ie, app pages, alert messages), page sequences (ie, path after a “click”), video, and text for the audio exercises were created by the first author (AP) under the supervision of TL and YK. The team partnered with the <italic>open house</italic> studio for the recording of the audio exercises; the instructions on the reading rhythm and tone of voice were developed by AP. We then worked in close collaboration with a computer engineering firm (<italic>psyX</italic> innovation) to develop the app and its various functionalities (eg, creation of a patient user account, welcome email upon creation of the patient user account, reset of lost passwords by sending an email, notification system [alerts] for mood evaluation, strategy modules, strategy evaluation module, user profile module, log tables, web access to log tables by the research team). Meetings with AP and the engineering team were held to adjust the preliminary versions of the app. The legal team of the research center of l’Institut Universitaire en Santé Mentale de Montréal (IUSMM) ensured that the copyright of the product reverts to the research center that the majority of the authors are affiliated with.</p>
        </sec>
        <sec>
          <title>Notification System for Mood Assessment</title>
          <p>The system was programed to offer mood assessment via two notifications per day at different times during the week (eg, Monday 10 AM and 3 PM, Tuesday 2 PM and 6 PM). Users who had made a negative assessment of their current state (assessed on a 3-point Likert scale [ie, good, neutral, bad]) were automatically directed to the app and offered a strategy adjusted to their preferences (see Strategy Assessment section below for details on customizing the choices of strategies). The user could also decide to initiate the use of the app without first being notified.</p>
        </sec>
        <sec>
          <title>Strategy Assessment</title>
          <p>To customize the app to each person’s preferences, the artificial intelligence component memorizes the user’s previous preferred strategies. Toward this end, the user has to assess each completed strategy on a 3-point Likert scale (ie, good, neutral, bad) immediately after its use. After the user has assessed 20 strategies, the app is programed to propose the use of a strategy that has been positively evaluated on 75% or more occasions after their next mood assessment (eg, if a user reports not feeling well, the strategies they preferred in the past will be offered first, as well as a randomly selected strategy to encourage the user to try a new, less familiar strategy). To ensure confidentiality, no information about the user’s preferences is stored on the phone, which is stored on a server accessible only to the research team.</p>
          <p>The selection of exercises was extracted from the literature [<xref ref-type="bibr" rid="ref49">49</xref>-<xref ref-type="bibr" rid="ref57">57</xref>] based on the following three criteria: easy to use anywhere, anytime; does not require planning or support; and easy to understand. The choice of strategies was informed by third-wave cognitive behavioral therapy approaches and determined by the research team. We chose these approaches because of the encouraging results reported in interventions for issues related to psychosis and substance use [<xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref58">58</xref>,<xref ref-type="bibr" rid="ref59">59</xref>]. A total of 20 coping strategies (selected by the research team among the most effective recognized strategies [<xref ref-type="bibr" rid="ref49">49</xref>-<xref ref-type="bibr" rid="ref57">57</xref>]) were divided into the following four categories (<xref rid="figure1" ref-type="fig">Figure 1</xref>): (1) <italic>behavioral (physical)</italic>, including diaphragmatic breathing, cardiac coherence, physical exercise (<xref rid="figure2" ref-type="fig">Figure 2</xref>), progressive muscle relaxation, and diving exercises; (2) <italic>emotional</italic>, including sharing my emotions, self-compassion, hugs, seeking laughter, and pleasant activities for the five senses; (3) <italic>cognitive</italic>, including problem solving (<xref rid="figure3" ref-type="fig">Figure 3</xref>), mindfulness strategies (body scan, self-observation, mindful walking (<xref rid="figure4" ref-type="fig">Figure 4</xref>), mindful breathing), and visualizing a safe place; and (4) <italic>spiritual</italic>, including praying, forgiveness, seeking spiritual advice from a spiritual leader, and reading religious texts. Different strategies were presented in different formats (ie, texts, videos, and audio tracks) to better adjust to the user’s preferences.</p>
          <fig id="figure1" position="float">
            <label>Figure 1</label>
            <caption>
              <p>Menu of the four categories of coping strategies. From top to bottom: Meditation and reflection, Breathing and relaxation, Sharing my emotions, Spiritual.</p>
            </caption>
            <graphic xlink:href="formative_v7i1e37293_fig1.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
          </fig>
          <fig id="figure2" position="float">
            <label>Figure 2</label>
            <caption>
              <p>Physical exercises. From top to bottom: Intense exercise: aerobic dance, running, climbing, biking, quickly going up and down stairs.</p>
            </caption>
            <graphic xlink:href="formative_v7i1e37293_fig2.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
          </fig>
          <fig id="figure3" position="float">
            <label>Figure 3</label>
            <caption>
              <p>Problem solving. From top to bottom: Restart (in red), What is my problem? Space to describe the problem (white box), My solutions, Choose a solution, Talk about it, Apply the solution.</p>
            </caption>
            <graphic xlink:href="formative_v7i1e37293_fig3.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
          </fig>
          <fig id="figure4" position="float">
            <label>Figure 4</label>
            <caption>
              <p>Mindful Walking.</p>
            </caption>
            <graphic xlink:href="formative_v7i1e37293_fig4.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
          </fig>
        </sec>
        <sec>
          <title>Beta Version of the App: Focus Group</title>
          <p>To ensure that we considered the user experience and users’ preferences in the app design, a focus group consisting of four participants was conducted using a beta version of the app. The research team contacted the administrators of the first-episode psychosis clinic at the IUSMM to recruit patients. They were asked to present the project to various clinicians who could then refer us to the patients who had expressed an interest in participating in the focus group.</p>
          <p>This phase consisted of a 2-hour meeting that was structured in two parts: (1) 1-hour use of the app and (2) completion of a satisfaction questionnaire inspired by the work of Ben-Zeev et al [<xref ref-type="bibr" rid="ref60">60</xref>] to measure the usefulness and ease of use, along with an open-ended questionnaire on what they liked about the intervention (ie, ease of use, relevance of the exercises, simplicity of the instructions, difficulties they might have faced during the short practice time, best time of the day to use the app) to have the opportunity to receive input from the participants on what they would change about to the app for it to be better suited to their needs. Questionnaires were provided individually (not in a group format). The data collected indicated that the participants found the app to be easy to use and potentially useful in managing their anxiety. Participants reported bugs of the videos that were adjusted by the team before beginning the pilot study.</p>
        </sec>
      </sec>
      <sec>
        <title>Pilot Study</title>
        <sec>
          <title>Design and Procedures</title>
          <p>This open pilot study followed a pre-post style design. After the initial assessment, researchers asked participants to use the app as part of their treatment over a 30-day period. A research assistant contacted participants by phone during the trial period to provide support and answer questions about using the app when they did not show any activity for more than 5 days (ie, no assessments and/or exercises recorded on the app manager net interface [managed by the team] for more than 5 days).</p>
        </sec>
        <sec>
          <title>Participant Recruitment</title>
          <p>The research team first distributed advertisements to the heads of the four hospital units (ie, two outpatient clinical services and two inpatient units) involved and met with the clinical teams to present the project. Clinicians approached their patients to see if they were interested and then referred them to the researchers after they expressed interest in participating. No further involvement (eg, encouragement of app use) was requested from the clinicians.</p>
          <p>Inclusion criteria were a dual diagnosis of a schizophrenia spectrum disorder with an SUD diagnosed by the treating psychiatrist, less than 35 years old (age limit in the participating clinics), interest in the study, and informed consent. Participants with neurological disorders, vision problems, or significant motor problems that could compromise the ability to handle a smartphone were excluded.</p>
          <p>The participant flow chart is shown in <xref rid="figure5" ref-type="fig">Figure 5</xref>. A total of 18 patients were referred to us by professionals at participating centers (convenience sample). The research team was able to contact 17 potential participants; one participant did not return our calls. Two participants withdrew after the first meeting (ie, focus group on the beta version) with the research team stating that they were no longer interested in participating, and two other participants were excluded because they did not meet the inclusion criteria established for this study. Of the 13 participants included at the beginning of the pilot study (ie, “beginning of the project” in <xref rid="figure5" ref-type="fig">Figure 5</xref>), two withdrew after the first meeting. One of them mentioned that he wanted to end his participation because the project “wasn’t his kind of thing” and the other patient did not give a reason for withdrawal. Analyses were performed on the remaining 11 study completers.</p>
          <fig id="figure5" position="float">
            <label>Figure 5</label>
            <caption>
              <p>Flow of participants for the given study procedure.</p>
            </caption>
            <graphic xlink:href="formative_v7i1e37293_fig5.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
          </fig>
        </sec>
        <sec>
          <title>Participant Characteristics</title>
          <p>Information regarding the age, gender, marital status, education level, vision disorders, and other basic characteristics was collected using a sociodemographic questionnaire. The treating psychiatrist diagnostic was confirmed by a doctoral student in psychology using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-5 (SCID-5) manual for diagnosis.</p>
          <p>A total of 13 individuals were recruited from two first-episode psychosis clinics (inpatient and outpatient) in Montreal (ie, Clinique Connect TI–IUSMM, Clinique JAP–Centre Hospitalier de l’Université de Montréal [CHUM]). Participants’ ongoing treatment consisted of a 3-year follow-up in which patients are supervised by a team composed of psychiatrists, occupational therapists, psycho-educators, and social workers. The objectives of this program are: symptomatic stabilization, integration into work and studies, education about psychosis, and education for the patients’ families. All participants included in the study were symptomatically stable. Participants were between 18 and 35 years of age and had a schizophrenia spectrum disorder with a substance use diagnosis (<xref ref-type="table" rid="table1">Table 1</xref>). Two participants mentioned having no drug use problems during the SCID interview (we indicated the diagnosis of the treating psychiatrist), but acknowledged substance use. Cannabis and alcohol were the most commonly used substances. Among the 11 participants, 5 (46%) participants reported using cannabis daily or almost daily. <xref ref-type="table" rid="table1">Table 1</xref> shows more details on the types of the most commonly used substances within the last 12 months and the other clinical and demographic characteristics.</p>
          <table-wrap position="float" id="table1">
            <label>Table 1</label>
            <caption>
              <p>Participant characteristics (N=11).</p>
            </caption>
            <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
              <col width="30"/>
              <col width="700"/>
              <col width="270"/>
              <thead>
                <tr valign="top">
                  <td colspan="2">Characteristic</td>
                  <td>Value</td>
                </tr>
              </thead>
              <tbody>
                <tr valign="top">
                  <td colspan="2">Age (years), mean (SD)</td>
                  <td>27.6 (4.5)</td>
                </tr>
                <tr valign="top">
                  <td colspan="2">Gender (men), n (%)</td>
                  <td>9 (82)</td>
                </tr>
                <tr valign="top">
                  <td colspan="2">Education (years), mean (SD)</td>
                  <td>9.7 (2.0)</td>
                </tr>
                <tr valign="top">
                  <td colspan="2">Marital status (single), n (%)</td>
                  <td>10 (91)</td>
                </tr>
                <tr valign="top">
                  <td colspan="3">
                    <bold>Diagnosis, n (%)</bold>
                  </td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Schizophrenia only</td>
                  <td>1 (9)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Schizophrenia+SUD<sup>a</sup></td>
                  <td>6 (55)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Schizophrenia+SUD+MDD<sup>b</sup></td>
                  <td>2 (18)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Schizoaffective disorder+SUD</td>
                  <td>1 (3)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Psychosis NOS<sup>c</sup></td>
                  <td>1 (9)</td>
                </tr>
                <tr valign="top">
                  <td colspan="3">
                    <bold>ASSIST<sup>d</sup>: substances taken at least 1 or 2 times in the past 3 months, n (%)</bold>
                  </td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Alcohol</td>
                  <td>9 (82)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Cannabis</td>
                  <td>10 (91)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Amphetamine</td>
                  <td>5 (46)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Cocaine</td>
                  <td>4 (36)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Painkillers or sleeping pills</td>
                  <td>2 (18)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Hallucinogens</td>
                  <td>2 (18)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="table1fn1">
                <p><sup>a</sup>SUD: substance use disorder.</p>
              </fn>
              <fn id="table1fn2">
                <p><sup>b</sup>MDD: major depressive disorder.</p>
              </fn>
              <fn id="table1fn3">
                <p><sup>c</sup>NOS: schizophrenia spectrum and other psychotic disorder not otherwise specified.</p>
              </fn>
              <fn id="table1fn4">
                <p><sup>d</sup>ASSIST: Alcohol, Smoking and Substance Involvement Screening Test.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec>
        <title>Data Collection</title>
        <p>The analysis consisted of between-subject comparisons in a pre-post prospective design. No masking was used to blind the interviewers to the study variables. Data collection (ie, semistructured interviews and questionnaires) was carried out by three authors (AP, GR, and CV). AP was also responsible for the initial contact with the participants and for providing technical support during the trial period. Data were collected by face-to-face meetings, teleconference, or by telephone (“pre” time period). All participants were informed of the study goals and signed a consent form at the first interview. The meetings lasted between 2 and 2.5 hours. The recruitment time frame was from January to November 2020. The scales measuring symptomatic presentations (ie, SCID-5, Brief Psychiatric Rating Scale-Expanded [BPRS-E]) were administered by a trained interviewer. The interviewer introduced the mobile app and provided information on its functioning after administering all scales. The second meeting (ie, “post” time period) followed the same format with the addition of the acceptability measures presented below.</p>
      </sec>
      <sec>
        <title>Measures</title>
        <sec>
          <title>Feasibility</title>
          <p>Feasibility was determined by the frequency of use of the app and was measured using the number of <italic>completed</italic> strategies (eg, listening to the entire length of a meditation recording and clicking a button to confirm that the exercise was completed). Moments of interaction with the app (eg, opening the app and looking at different exercises without selecting any of them) or partially completed exercises (eg, listening to only half of the meditation recording) were not counted as moments of use. We also included a measure of attrition as an index of feasibility. Based on previous studies of cannabis users [<xref ref-type="bibr" rid="ref61">61</xref>] and cannabis users who have recently experienced a psychotic episode [<xref ref-type="bibr" rid="ref62">62</xref>], we estimated that attrition would reach a maximum of approximately 30%.</p>
        </sec>
        <sec>
          <title>Acceptability</title>
          <p>Acceptability was determined by measuring ease of use, ease of learning, satisfaction, and perceived utility at the end of the 30-day study period by using the same scales as used in the focus group: (1) a satisfaction questionnaire inspired by the work of Ben-Zeev et al [<xref ref-type="bibr" rid="ref60">60</xref>] and (2) a questionnaire with open-ended questions assessing participant impressions of what they liked about the intervention and what they would change.</p>
        </sec>
        <sec>
          <title>Clinical Scales</title>
          <p>The clinical scales were administered at the beginning and end of the 30-day study period with the exception of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), which was administered only at the beginning of the trial period.</p>
          <p>The Cognitive Emotion Regulation Questionnaire (CERQ) was used to assess nine cognitive dimensions of emotional regulation (self-blame, acceptance, rumination, positive centering, action centering, positive reappraisal, perspective taking, dramatization, blame others). This instrument consists of 36 items rated on a 5-point Likert-type scale ranging from “almost never” to “almost all the time” (internal consistency: α=.75-.87 depending on the subscale) [<xref ref-type="bibr" rid="ref63">63</xref>]. The questionnaire also included second-order factors grouped into adaptive (ie, acceptance, positive refocusing, refocus on planning, positive reappraisal, and putting into perspective) and less-adaptive (ie, self-blame, rumination, catastrophizing, and blaming others) strategies (internal consistency: α=.91 for adaptive and α=.87 for less-adaptive strategies [<xref ref-type="bibr" rid="ref61">61</xref>]).</p>
          <p>The BPRS-E [<xref ref-type="bibr" rid="ref62">62</xref>] was used to measure different psychiatric symptoms (eg, positive, negative, anxiety, depressive symptoms). The instrument is composed of 24 items rated on a 7-point Likert-type scale ranging from “not present” to “extremely severe” (internal consistency: α =.81 for positive symptoms and α=.91 for negative symptoms).</p>
          <p>The semistructured Time-Line Follow Back (TLFB) interview [<xref ref-type="bibr" rid="ref64">64</xref>] was used to assess the age of onset of use, and the amount and category of substances the participant may have used in the last month for each week. In terms of metrological qualities, correlations as high as 0.96 in validity and test-retest reliability have been reported for this instrument [<xref ref-type="bibr" rid="ref65">65</xref>].</p>
          <p>The ASSIST [<xref ref-type="bibr" rid="ref66">66</xref>] was used to assess the severity of addictions. This instrument consists of eight questions addressing tobacco, cannabis, cocaine, stimulants, hallucinogens, opiates, and other drug use. The dimensions assessed through these eight questions are: (1) the substance used, (2) the frequency of use, (3) the desire to use (“craving”), (4) psychosocial problems that could have resulted from use, (5) difficulties in fulfilling one’s obligations related to use, and (6) other problems that could be related to drug use. Questions related to each theme are rated on a 5-, 3-, or 2-point Likert-type scale (internal consistency of the French version: α=.93) [<xref ref-type="bibr" rid="ref67">67</xref>].</p>
        </sec>
      </sec>
      <sec>
        <title>Statistical Analysis</title>
        <p>Descriptive statistics are used to report the frequency and distribution of the different patient characteristics (diagnoses, sociodemographic variables, and clinical variables), as well as the frequency of use and perceived usefulness. The difference between the measurements at the beginning and end of the 30-day study period on the clinical and emotion regulation scales was assessed using a <italic>t</italic> test for paired data.</p>
      </sec>
      <sec>
        <title>Ethics Considerations</title>
        <p>The study was approved by the respective ethics committees of the research centers of the IUSMM (approval number MP-12-2018-1420) and the CHUM (approval number MEO-12-2021-9143). All participants signed a consent form.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Feasibility</title>
        <p>Participants used (ie, frequency of use of the app and the number of <italic>completed</italic> strategies) the app on average 33% of days during the project period. Approximately half of the patients (5/11) used the tool at least 33% of the days (11-21 days) while the other half used it 27% of the days or less (5-8 days) during the project. Data from two participants could only be partially recorded because of difficulties in logging into the app’s user account. The attrition rate was 18%.</p>
      </sec>
      <sec>
        <title>Acceptability</title>
        <p>The frequency of use of the different categories of exercises and their evaluation by users are presented in <xref ref-type="table" rid="table2">Table 2</xref>. In terms of preferences of exercise categories, cognitive and emotion-focused techniques were rated the highest in terms of usefulness and were the most frequently used. The behavioral exercises were used slightly less frequently. The “spiritual” category was the least used and also received the lowest score. The majority of participants gave positive answers about the ease of use (eg, 81.8% agreed with the statement “Overall, using ChillTime was easy”) and the ease of learning the tool (eg, 81.8% agreed with the statement “I feel it is easy to learn to use ChillTime”). Furthermore, 90% of participants would recommend ChillTime to a friend. In terms of satisfaction, 55% responded that ChillTime is a tool that they would use daily and 73% indicated that the different sections of ChillTime complemented each other well. In terms of usefulness, 55% indicated that ChillTime had helped them in difficult times.</p>
        <p>In their responses to the open-ended acceptability questionnaire on their impressions of the app at the end of the 30-day trial period, several participants mentioned the beneficial effect of the app in calming their anxiety. More specifically, the mindfulness meditation and cardiac coherence exercises were often named as being particularly useful for this purpose. Some respondents also specified that they would rather use the app when needed (eg, during a crisis) than on a daily basis. In terms of exercise format, several participants mentioned that they particularly appreciated the exercises with audio or simple animation. In terms of difficulties encountered in using the app, many participants pointed out that it was difficult for them to carry out the exercises outside their house because of distractions and ambient noise (eg, noise in the subway).</p>
        <table-wrap position="float" id="table2">
          <label>Table 2</label>
          <caption>
            <p>Relative overall use and subjective utility of the different categories of exercises used.</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="390"/>
            <col width="310"/>
            <col width="300"/>
            <thead>
              <tr valign="bottom">
                <td>Category</td>
                <td>Usage (%)</td>
                <td>Average rating<sup>a</sup></td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td>Cognitive</td>
                <td>36</td>
                <td>2.54</td>
              </tr>
              <tr valign="top">
                <td>Behavioral</td>
                <td>21</td>
                <td>2.42</td>
              </tr>
              <tr valign="top">
                <td>Emotion-focused</td>
                <td>34</td>
                <td>2.67</td>
              </tr>
              <tr valign="top">
                <td>Spiritual</td>
                <td>9</td>
                <td>2.20</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="table2fn1">
              <p><sup>a</sup>Subjective usefulness assessed on the app with a 3-point Likert scale (1=not useful, 2=neutral, 3=useful).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Potential Clinical Effects</title>
        <p>The results on the clinical scales are presented in <xref ref-type="table" rid="table3">Table 3</xref>. A nonsignificant reduction was found in the pre-post level of the negative symptoms scale of the BPRS-E in the paired sample <italic>t</italic> test (<italic>P</italic>=.05). No significant difference between pre and post scores on the CERQ and the TLFB were found.</p>
        <table-wrap position="float" id="table3">
          <label>Table 3</label>
          <caption>
            <p>Questionnaire scores and clinical variables at baseline (T0) and after the 30-day trial period (T1).</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="30"/>
            <col width="500"/>
            <col width="270"/>
            <col width="200"/>
            <thead>
              <tr valign="top">
                <td colspan="2">Variable</td>
                <td>T0, mean (SD)</td>
                <td>T1, mean (SD)</td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td colspan="2">Brief Psychiatric Rating Scale-Expanded (BPRS-E): negative symptoms</td>
                <td>7 (2.07)</td>
                <td>5.9 (1.46)</td>
              </tr>
              <tr valign="top">
                <td colspan="4">
                  <bold>Cognitive Emotion Regulation Questionnaire (CERQ)</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Use of more adaptive strategies</td>
                <td>69.25 (14.73)</td>
                <td>65.69 (15.46)</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Use of less adaptive strategies</td>
                <td>39.19 (6.04)</td>
                <td>38.0 (7.84)</td>
              </tr>
              <tr valign="top">
                <td colspan="4">
                  <bold>Time-Line Follow Back (TLFB): number of days used (30-day period)</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Cannabis</td>
                <td>17.29 (11.47)</td>
                <td>10.25 (9.88)</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Amphetamine</td>
                <td>18.33 (13.43)</td>
                <td>6.00 (12.33)</td>
              </tr>
              <tr valign="top">
                <td colspan="4">
                  <bold>TLFB: total amount used (30-day period)</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Cannabis (grams)</td>
                <td>23.29 (25.43)</td>
                <td>17.00 (25.59)</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Amphetamine (number of pills)</td>
                <td>26.00 (34.38)</td>
                <td>3.00 (6.16)</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <sec>
        <title>Principal Findings</title>
        <sec>
          <title>Design</title>
          <p>This study aimed to evaluate the feasibility, acceptability, and potential impact of the ChillTime app intervention to promote better emotional regulation for psychological distress in individuals with psychotic and concurrent substance use disorders treated in an outpatient setting in the greater Montreal area. The app was designed on the base of Rotondi et al’s [<xref ref-type="bibr" rid="ref48">48</xref>] recommendations for reducing cognitive effort on a mobile app.</p>
        </sec>
        <sec>
          <title>Feasibility</title>
          <p>Our results suggest that the use of ChillTime appears feasible. The frequency of use of the app was lower than that found in other studies assessing apps targeting social anxiety [<xref ref-type="bibr" rid="ref41">41</xref>] or psychosis [<xref ref-type="bibr" rid="ref60">60</xref>]. This difference could be explained in part by a more stringent method of measurement used to record usage. In this study, only completed exercises were compiled by the app, which differs from studies that count every time participants interact with the tool (eg, [<xref ref-type="bibr" rid="ref60">60</xref>]). In addition, the fact that several participants reported in the open-ended acceptability questionnaire that ChillTime requires (for some exercises) a quieter environment could also have contributed to lower usage than a tool that primarily employs self-monitoring [<xref ref-type="bibr" rid="ref40">40</xref>]. Indeed, completing a self-reported questionnaire is less likely to require an environment free of ambient noise than listening to an audio track of guided meditation. These results suggest that the feasibility of ChillTime could potentially be improved if more exercises were adapted to environments with ambient noise (eg, more text than audio recordings). Alternatively, the app could subdivide the exercises according to the environment (ie, “exercises to be done in a quiet place” and “exercises for noisier places”). It is also possible that a learning effect influenced the frequency of use of the app (ie, a participant having memorized the technique does not feel the need to use the app as much). In our small sample, half of the participants used ChillTime more than 33% of the days throughout the study. These results are consistent with results reported in similar studies with cannabis users [<xref ref-type="bibr" rid="ref68">68</xref>] and cannabis users who had a recent psychotic episode [<xref ref-type="bibr" rid="ref69">69</xref>]. These results are also consistent with the expected completion rate in a population with dual disorder (with cannabis use) [<xref ref-type="bibr" rid="ref70">70</xref>]. A larger study may allow us to replicate this usage pattern and see whether it is associated with certain patient characteristics. This could enable better targeting toward individuals who are more likely to benefit from the app. Attrition was within the acceptable range.</p>
        </sec>
        <sec>
          <title>Acceptability</title>
          <p>Our results suggest that ChillTime is acceptable to participants. These results are consistent with other studies that have used mobile apps with a similar population [<xref ref-type="bibr" rid="ref39">39</xref>-<xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref60">60</xref>]. The preference in terms of categories may be partly explained by the fact that the three most popular categories (ie, behavioral, emotional, and cognitive) contained different strategy formats, including an audio format (which was appreciated by the participants). This contrasts with strategies in the spiritual category that were only in text format.</p>
          <p>It is important to mention that such preferences need to be replicated before drawing generalizable conclusions, as such preferences are possibly influenced by cultural aspects. Nevertheless, this study is one of the few that assessed user preferences for different emotion regulation strategies. Most of the previous apps-related intervention studies investigated some strategies but for a specific problem (eg, medication adherence [<xref ref-type="bibr" rid="ref60">60</xref>], loneliness [<xref ref-type="bibr" rid="ref41">41</xref>]) or a single bundle of strategies (eg, dialectical behavior therapy [<xref ref-type="bibr" rid="ref47">47</xref>]). Once our results are replicated, these insights could contribute toward optimizing the app for this population.</p>
          <p>The ChillTime app was frequently used by a portion of the participants and, based on the responses on the qualitative questionnaire, was considered useful for managing certain symptomatic manifestations (ie, anxiety). It was also judged as a tool with good acceptability.</p>
        </sec>
        <sec>
          <title>Potential Clinical Effects</title>
          <p>Although the differences on the clinical scales did not reach the significance threshold, trends were observed. Among them, we can question the potential effect of the app on the reduction of negative symptoms. A future study with a larger sample would allow us to confirm this trend. Furthermore, a reduction in negative symptoms has also been observed in other studies using an app tested among individuals with psychosis (ie, [<xref ref-type="bibr" rid="ref60">60</xref>]). To our surprise, no significant differences were observed on the emotional regulation abilities assessed by the CERQ. It is possible that the short duration of the study (ie, 30 days) was not sufficient to promote change in the various skills assessed or that the emotion regulation measure was not close enough to the strategies used in the app. In terms of substance use, measured by the TLFB, the differences observed between the two measurement periods did not produce significant differences. This could be partly due to the high variability of the different observations and the small sample size. Although not significant, the large difference in terms of quantities and frequency of drug use points to a potential effect of the app on drug use, which would also need to be confirmed in a larger study.</p>
        </sec>
      </sec>
      <sec>
        <title>Limitations</title>
        <p>This study has several limitations when compared to a true outcome study. The sample size of the study was small and there was no randomization or control group. These limitations make it difficult to interpret the results on the clinical scales (eg, to determine the representativeness of the sample). A larger study is needed to replicate the results and determine the potential efficacy or real-world effectiveness of the app in helping people with comorbid psychotic and substance misuse disorders improve in emotion regulation. In addition, the study was conducted over a short period of time (ie, 30 days). Some processes (eg, affective regulation capacity) may take longer to change in a given individual, therefore requiring longer studies. Another limitation of the study is the recruitment strategy. Since this was a convenience sample, only those interested in participating were recruited. Therefore, this sample may not be representative of the population. It would also be important for a future study to further explore the characteristics of participants who used the app less to better understand why their level of participation was lower.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p>Despite these limitations, this study shows encouraging results for the relevance of pursuing the development and studies of apps that provide immediate support to patients with psychosis and concomitant substance use disorders presenting emotional regulation difficulties.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group/>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term id="abb1">ASSIST</term>
          <def>
            <p>Alcohol, Smoking and Substance Involvement Screening Test</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb2">BPRS-E</term>
          <def>
            <p>Brief Psychiatric Rating Scale-Expanded</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb3">CERQ</term>
          <def>
            <p>Cognitive Emotion Regulation Questionnaire</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb4">CHUM</term>
          <def>
            <p>Centre Hospitalier de l’Université de Montréal</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb5">IUSMM</term>
          <def>
            <p>l’Institut Universitaire en Santé Mentale de Montréal</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb6">SCID-5</term>
          <def>
            <p>Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-5</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb7">SUD</term>
          <def>
            <p>substance use disorder</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb8">TLFB</term>
          <def>
            <p>Time-Line Follow Back</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <p>We would like to acknowledge the important collaboration of Noémie Noiseux. She actively participated in the recruitment process by promoting the project to the various mental health workers and supported the research team throughout the recruitment period. We would also like to thank Vincent Borgeat and Etienne Borgeat from PsyX innovation who helped in app development.</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p>TL, YK, and SP are linked to the research center (ie, Centre de Recherche de l’Institut Universitaire en Santé Mentale de Montréal) receiving profits made from the app’s use (sold on Google Play store). These profits are reinvested in research and app updates. The other authors have no conflicts to declare.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Aleman</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Kahn</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia?</article-title>
          <source>Prog Neurobiol</source>
          <year>2005</year>
          <month>12</month>
          <volume>77</volume>
          <issue>5</issue>
          <fpage>283</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pneurobio.2005.11.005</pub-id>
          <pub-id pub-id-type="medline">16352388</pub-id>
          <pub-id pub-id-type="pii">S0301-0082(05)00167-X</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bonfils</surname>
              <given-names>KA</given-names>
            </name>
            <name name-style="western">
              <surname>Lysaker</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>Levels of distress tolerance in schizophrenia appear equivalent to those found in borderline personality disorder</article-title>
          <source>J Clin Psychol</source>
          <year>2020</year>
          <month>09</month>
          <volume>76</volume>
          <issue>9</issue>
          <fpage>1668</fpage>
          <lpage>1676</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/32068895"/>
          </comment>
          <pub-id pub-id-type="doi">10.1002/jclp.22944</pub-id>
          <pub-id pub-id-type="medline">32068895</pub-id>
          <pub-id pub-id-type="pmcid">PMC7725405</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kimhy</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Lister</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Vakhrusheva</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Delespaul</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Malaspina</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Ospina</surname>
              <given-names>LH</given-names>
            </name>
            <name name-style="western">
              <surname>Mittal</surname>
              <given-names>VA</given-names>
            </name>
            <name name-style="western">
              <surname>Gross</surname>
              <given-names>JJ</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>The impact of emotion awareness and regulation on psychotic symptoms during daily functioning</article-title>
          <source>NPJ Schizophr</source>
          <year>2020</year>
          <month>03</month>
          <day>24</day>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>7</fpage>
          <pub-id pub-id-type="doi">10.1038/s41537-020-0096-6</pub-id>
          <pub-id pub-id-type="medline">32210232</pub-id>
          <pub-id pub-id-type="pii">10.1038/s41537-020-0096-6</pub-id>
          <pub-id pub-id-type="pmcid">PMC7093537</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Livingstone</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Harper</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Gillanders</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>An exploration of emotion regulation in psychosis</article-title>
          <source>Clin Psychol Psychother</source>
          <year>2009</year>
          <volume>16</volume>
          <issue>5</issue>
          <fpage>418</fpage>
          <lpage>430</lpage>
          <pub-id pub-id-type="doi">10.1002/cpp.635</pub-id>
          <pub-id pub-id-type="medline">19569041</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>van der Meer</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>van't Wout</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Aleman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Emotion regulation strategies in patients with schizophrenia</article-title>
          <source>Psychiatry Res</source>
          <year>2009</year>
          <month>12</month>
          <day>30</day>
          <volume>170</volume>
          <issue>2-3</issue>
          <fpage>108</fpage>
          <lpage>113</lpage>
          <pub-id pub-id-type="doi">10.1016/j.psychres.2009.07.010</pub-id>
          <pub-id pub-id-type="medline">19906439</pub-id>
          <pub-id pub-id-type="pii">S0165-1781(09)00277-7</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Fox</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Axelrod</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Paliwal</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Sleeper</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Sinha</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Difficulties in emotion regulation and impulse control during cocaine abstinence</article-title>
          <source>Drug Alcohol Depend</source>
          <year>2007</year>
          <month>07</month>
          <day>10</day>
          <volume>89</volume>
          <issue>2-3</issue>
          <fpage>298</fpage>
          <lpage>301</lpage>
          <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2006.12.026</pub-id>
          <pub-id pub-id-type="medline">17276626</pub-id>
          <pub-id pub-id-type="pii">S0376-8716(06)00488-1</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Fox</surname>
              <given-names>HC</given-names>
            </name>
            <name name-style="western">
              <surname>Hong</surname>
              <given-names>KA</given-names>
            </name>
            <name name-style="western">
              <surname>Sinha</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Difficulties in emotion regulation and impulse control in recently abstinent alcoholics compared with social drinkers</article-title>
          <source>Addict Behav</source>
          <year>2008</year>
          <month>02</month>
          <volume>33</volume>
          <issue>2</issue>
          <fpage>388</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="doi">10.1016/j.addbeh.2007.10.002</pub-id>
          <pub-id pub-id-type="medline">18023295</pub-id>
          <pub-id pub-id-type="pii">S0306-4603(07)00287-0</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Garke</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>Isacsson</surname>
              <given-names>NH</given-names>
            </name>
            <name name-style="western">
              <surname>Sörman</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Bjureberg</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Hellner</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Gratz</surname>
              <given-names>KL</given-names>
            </name>
            <name name-style="western">
              <surname>Berghoff</surname>
              <given-names>CR</given-names>
            </name>
            <name name-style="western">
              <surname>Sinha</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Tull</surname>
              <given-names>MT</given-names>
            </name>
            <name name-style="western">
              <surname>Jayaram-Lindström</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Emotion dysregulation across levels of substance use</article-title>
          <source>Psychiatry Res</source>
          <year>2021</year>
          <month>02</month>
          <volume>296</volume>
          <fpage>113662</fpage>
          <pub-id pub-id-type="doi">10.1016/j.psychres.2020.113662</pub-id>
          <pub-id pub-id-type="medline">33406445</pub-id>
          <pub-id pub-id-type="pii">S0165-1781(20)33323-0</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Wilcox</surname>
              <given-names>CE</given-names>
            </name>
            <name name-style="western">
              <surname>Pommy</surname>
              <given-names>JM</given-names>
            </name>
            <name name-style="western">
              <surname>Adinoff</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Neural circuitry of impaired emotion regulation in substance use disorder</article-title>
          <source>Am J Psychiatry</source>
          <year>2016</year>
          <month>04</month>
          <day>01</day>
          <volume>173</volume>
          <issue>4</issue>
          <fpage>344</fpage>
          <lpage>361</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/26771738"/>
          </comment>
          <pub-id pub-id-type="doi">10.1176/appi.ajp.2015.15060710</pub-id>
          <pub-id pub-id-type="medline">26771738</pub-id>
          <pub-id pub-id-type="pmcid">PMC4979988</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bailer</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Witthöft</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Erkic</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Mier</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Emotion dysregulation in hypochondriasis and depression</article-title>
          <source>Clin Psychol Psychother</source>
          <year>2017</year>
          <month>11</month>
          <volume>24</volume>
          <issue>6</issue>
          <fpage>1254</fpage>
          <lpage>1262</lpage>
          <pub-id pub-id-type="doi">10.1002/cpp.2089</pub-id>
          <pub-id pub-id-type="medline">28444850</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Garnefski</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Kraaij</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Specificity of relations between adolescents' cognitive emotion regulation strategies and symptoms of depression and anxiety</article-title>
          <source>Cogn Emot</source>
          <year>2018</year>
          <month>11</month>
          <volume>32</volume>
          <issue>7</issue>
          <fpage>1401</fpage>
          <lpage>1408</lpage>
          <pub-id pub-id-type="doi">10.1080/02699931.2016.1232698</pub-id>
          <pub-id pub-id-type="medline">27648495</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Malik</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Wells</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Wittkowski</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Emotion regulation as a mediator in the relationship between attachment and depressive symptomatology: a systematic review</article-title>
          <source>J Affect Disord</source>
          <year>2015</year>
          <month>02</month>
          <day>01</day>
          <volume>172</volume>
          <fpage>428</fpage>
          <lpage>444</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jad.2014.10.007</pub-id>
          <pub-id pub-id-type="medline">25451448</pub-id>
          <pub-id pub-id-type="pii">S0165-0327(14)00629-6</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Miles</surname>
              <given-names>SR</given-names>
            </name>
            <name name-style="western">
              <surname>Menefee</surname>
              <given-names>DS</given-names>
            </name>
            <name name-style="western">
              <surname>Wanner</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Teten Tharp</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Kent</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>The relationship between emotion dysregulation and impulsive aggression in veterans with posttraumatic stress disorder symptoms</article-title>
          <source>J Interpers Violence</source>
          <year>2016</year>
          <month>06</month>
          <volume>31</volume>
          <issue>10</issue>
          <fpage>1795</fpage>
          <lpage>1816</lpage>
          <pub-id pub-id-type="doi">10.1177/0886260515570746</pub-id>
          <pub-id pub-id-type="medline">25681165</pub-id>
          <pub-id pub-id-type="pii">0886260515570746</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Weiss</surname>
              <given-names>NH</given-names>
            </name>
            <name name-style="western">
              <surname>Contractor</surname>
              <given-names>AA</given-names>
            </name>
            <name name-style="western">
              <surname>Forkus</surname>
              <given-names>SR</given-names>
            </name>
            <name name-style="western">
              <surname>Goncharenko</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Raudales</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Positive emotion dysregulation among community individuals: the role of trauma exposure and posttraumatic stress disorder</article-title>
          <source>J Trauma Stress</source>
          <year>2020</year>
          <month>10</month>
          <volume>33</volume>
          <issue>5</issue>
          <fpage>741</fpage>
          <lpage>749</lpage>
          <pub-id pub-id-type="doi">10.1002/jts.22497</pub-id>
          <pub-id pub-id-type="medline">32216154</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Carpenter</surname>
              <given-names>RW</given-names>
            </name>
            <name name-style="western">
              <surname>Trull</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>Components of emotion dysregulation in borderline personality disorder: a review</article-title>
          <source>Curr Psychiatry Rep</source>
          <year>2013</year>
          <month>01</month>
          <volume>15</volume>
          <issue>1</issue>
          <fpage>335</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/23250816"/>
          </comment>
          <pub-id pub-id-type="doi">10.1007/s11920-012-0335-2</pub-id>
          <pub-id pub-id-type="medline">23250816</pub-id>
          <pub-id pub-id-type="pmcid">PMC3973423</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sloan</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Hall</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Moulding</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Bryce</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Mildred</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Staiger</surname>
              <given-names>PK</given-names>
            </name>
          </person-group>
          <article-title>Emotion regulation as a transdiagnostic treatment construct across anxiety, depression, substance, eating and borderline personality disorders: a systematic review</article-title>
          <source>Clin Psychol Rev</source>
          <year>2017</year>
          <month>11</month>
          <volume>57</volume>
          <fpage>141</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cpr.2017.09.002</pub-id>
          <pub-id pub-id-type="medline">28941927</pub-id>
          <pub-id pub-id-type="pii">S0272-7358(16)30381-6</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Henry</surname>
              <given-names>JD</given-names>
            </name>
            <name name-style="western">
              <surname>Rendell</surname>
              <given-names>PG</given-names>
            </name>
            <name name-style="western">
              <surname>Green</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>McDonald</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>O'Donnell</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Emotion regulation in schizophrenia: affective, social, and clinical correlates of suppression and reappraisal</article-title>
          <source>J Abnorm Psychol</source>
          <year>2008</year>
          <month>05</month>
          <volume>117</volume>
          <issue>2</issue>
          <fpage>473</fpage>
          <lpage>478</lpage>
          <pub-id pub-id-type="doi">10.1037/0021-843X.117.2.473</pub-id>
          <pub-id pub-id-type="medline">18489225</pub-id>
          <pub-id pub-id-type="pii">2008-05639-024</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Pennou</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Lecomte</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Potvin</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Khazaal</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Mobile intervention for individuals with psychosis, dual disorders, and their common comorbidities: a literature review</article-title>
          <source>Front Psychiatry</source>
          <year>2019</year>
          <volume>10</volume>
          <fpage>302</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/31130884"/>
          </comment>
          <pub-id pub-id-type="doi">10.3389/fpsyt.2019.00302</pub-id>
          <pub-id pub-id-type="medline">31130884</pub-id>
          <pub-id pub-id-type="pmcid">PMC6510170</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Badcock</surname>
              <given-names>JC</given-names>
            </name>
            <name name-style="western">
              <surname>Paulik</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Maybery</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>The role of emotion regulation in auditory hallucinations</article-title>
          <source>Psychiatry Res</source>
          <year>2011</year>
          <month>02</month>
          <day>28</day>
          <volume>185</volume>
          <issue>3</issue>
          <fpage>303</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="doi">10.1016/j.psychres.2010.07.011</pub-id>
          <pub-id pub-id-type="medline">20678808</pub-id>
          <pub-id pub-id-type="pii">S0165-1781(10)00412-9</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Trower</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Birchwood</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Meaden</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Byrne</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Nelson</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Ross</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Cognitive therapy for command hallucinations: randomised controlled trial</article-title>
          <source>Br J Psychiatry</source>
          <year>2004</year>
          <month>04</month>
          <day>02</day>
          <volume>184</volume>
          <issue>4</issue>
          <fpage>312</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="doi">10.1192/bjp.184.4.312</pub-id>
          <pub-id pub-id-type="medline">15056575</pub-id>
          <pub-id pub-id-type="pii">S0007125000077758</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Morrison</surname>
              <given-names>AP</given-names>
            </name>
            <name name-style="western">
              <surname>French</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Walford</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Lewis</surname>
              <given-names>SW</given-names>
            </name>
            <name name-style="western">
              <surname>Kilcommons</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Green</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Parker</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Bentall</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial</article-title>
          <source>Br J Psychiatry</source>
          <year>2004</year>
          <month>10</month>
          <volume>185</volume>
          <fpage>291</fpage>
          <lpage>297</lpage>
          <pub-id pub-id-type="doi">10.1192/bjp.185.4.291</pub-id>
          <pub-id pub-id-type="medline">15458988</pub-id>
          <pub-id pub-id-type="pii">S000712500016547X</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gumley</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>O'Grady</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>McNay</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Reilly</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Power</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Norrie</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy</article-title>
          <source>Psychol Med</source>
          <year>2003</year>
          <month>04</month>
          <volume>33</volume>
          <issue>3</issue>
          <fpage>419</fpage>
          <lpage>431</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://core.ac.uk/reader/9050710?utm_source=linkout"/>
          </comment>
          <pub-id pub-id-type="doi">10.1017/s0033291703007323</pub-id>
          <pub-id pub-id-type="medline">12701663</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Andrés</surname>
              <given-names>ML</given-names>
            </name>
            <name name-style="western">
              <surname>del-Valle</surname>
              <given-names>MV</given-names>
            </name>
            <name name-style="western">
              <surname>Richaud de Minzi</surname>
              <given-names>MC</given-names>
            </name>
            <name name-style="western">
              <surname>Introzzi</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Canet-Juric</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Navarro-Guzmán</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>Distress tolerance and executive functions: a systematic review</article-title>
          <source>Psychol Neurosci</source>
          <year>2021</year>
          <month>09</month>
          <volume>14</volume>
          <issue>3</issue>
          <fpage>280</fpage>
          <lpage>297</lpage>
          <pub-id pub-id-type="doi">10.1037/pne0000259</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Nugent</surname>
              <given-names>KL</given-names>
            </name>
            <name name-style="western">
              <surname>Chiappelli</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Rowland</surname>
              <given-names>LM</given-names>
            </name>
            <name name-style="western">
              <surname>Daughters</surname>
              <given-names>SB</given-names>
            </name>
            <name name-style="western">
              <surname>Hong</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Distress intolerance and clinical functioning in persons with schizophrenia</article-title>
          <source>Psychiatry Res</source>
          <year>2014</year>
          <month>12</month>
          <day>15</day>
          <volume>220</volume>
          <issue>1-2</issue>
          <fpage>31</fpage>
          <lpage>36</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/25107316"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.psychres.2014.07.026</pub-id>
          <pub-id pub-id-type="medline">25107316</pub-id>
          <pub-id pub-id-type="pii">S0165-1781(14)00605-2</pub-id>
          <pub-id pub-id-type="pmcid">PMC4252749</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ludwig</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Werner</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Lincoln</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>The relevance of cognitive emotion regulation to psychotic symptoms - a systematic review and meta-analysis</article-title>
          <source>Clin Psychol Rev</source>
          <year>2019</year>
          <month>08</month>
          <volume>72</volume>
          <fpage>101746</fpage>
          <pub-id pub-id-type="doi">10.1016/j.cpr.2019.101746</pub-id>
          <pub-id pub-id-type="medline">31302506</pub-id>
          <pub-id pub-id-type="pii">S0272-7358(18)30411-2</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gregg</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Barrowclough</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Haddock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Reasons for increased substance use in psychosis</article-title>
          <source>Clin Psychol Rev</source>
          <year>2007</year>
          <month>05</month>
          <volume>27</volume>
          <issue>4</issue>
          <fpage>494</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cpr.2006.09.004</pub-id>
          <pub-id pub-id-type="medline">17240501</pub-id>
          <pub-id pub-id-type="pii">S0272-7358(06)00114-0</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Nesvåg</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Knudsen</surname>
              <given-names>GP</given-names>
            </name>
            <name name-style="western">
              <surname>Bakken</surname>
              <given-names>IJ</given-names>
            </name>
            <name name-style="western">
              <surname>Høye</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Ystrom</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Surén</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Reneflot</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Stoltenberg</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Reichborn-Kjennerud</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study</article-title>
          <source>Soc Psychiatry Psychiatr Epidemiol</source>
          <year>2015</year>
          <month>08</month>
          <volume>50</volume>
          <issue>8</issue>
          <fpage>1267</fpage>
          <lpage>1276</lpage>
          <pub-id pub-id-type="doi">10.1007/s00127-015-1025-2</pub-id>
          <pub-id pub-id-type="medline">25680837</pub-id>
          <pub-id pub-id-type="pii">10.1007/s00127-015-1025-2</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Thoma</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Daum</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings</article-title>
          <source>Psychiatry Clin Neurosci</source>
          <year>2013</year>
          <month>09</month>
          <volume>67</volume>
          <issue>6</issue>
          <fpage>367</fpage>
          <lpage>383</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://doi.org/10.1111/pcn.12072"/>
          </comment>
          <pub-id pub-id-type="doi">10.1111/pcn.12072</pub-id>
          <pub-id pub-id-type="medline">23890122</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mueser</surname>
              <given-names>KT</given-names>
            </name>
            <name name-style="western">
              <surname>Jeste</surname>
              <given-names>DV</given-names>
            </name>
          </person-group>
          <source>Clinical handbook of schizophrenia</source>
          <year>2008</year>
          <publisher-loc>New York, NY</publisher-loc>
          <publisher-name>Guilford Press</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cantor-Graae</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Nordström</surname>
              <given-names>LG</given-names>
            </name>
            <name name-style="western">
              <surname>McNeil</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden</article-title>
          <source>Schizophr Res</source>
          <year>2001</year>
          <month>03</month>
          <day>01</day>
          <volume>48</volume>
          <issue>1</issue>
          <fpage>69</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1016/s0920-9964(00)00114-6</pub-id>
          <pub-id pub-id-type="medline">11278155</pub-id>
          <pub-id pub-id-type="pii">S0920-9964(00)00114-6</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref31">
        <label>31</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Dixon</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes</article-title>
          <source>Schizophr Res</source>
          <year>1999</year>
          <month>03</month>
          <day>01</day>
          <volume>35</volume>
          <issue>Suppl</issue>
          <fpage>S93</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="doi">10.1016/s0920-9964(98)00161-3</pub-id>
          <pub-id pub-id-type="medline">10190230</pub-id>
          <pub-id pub-id-type="pii">S0920-9964(98)00161-3</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref32">
        <label>32</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hunt</surname>
              <given-names>GE</given-names>
            </name>
            <name name-style="western">
              <surname>Large</surname>
              <given-names>MM</given-names>
            </name>
            <name name-style="western">
              <surname>Cleary</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Lai</surname>
              <given-names>HMX</given-names>
            </name>
            <name name-style="western">
              <surname>Saunders</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis</article-title>
          <source>Drug Alcohol Depend</source>
          <year>2018</year>
          <month>10</month>
          <day>01</day>
          <volume>191</volume>
          <fpage>234</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2018.07.011</pub-id>
          <pub-id pub-id-type="medline">30153606</pub-id>
          <pub-id pub-id-type="pii">S0376-8716(18)30458-7</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref33">
        <label>33</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Moroz</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Moroz</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>D'Angelo</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Mental health services in Canada: Barriers and cost-effective solutions to increase access</article-title>
          <source>Healthc Manage Forum</source>
          <year>2020</year>
          <month>11</month>
          <volume>33</volume>
          <issue>6</issue>
          <fpage>282</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="doi">10.1177/0840470420933911</pub-id>
          <pub-id pub-id-type="medline">32613867</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref34">
        <label>34</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Wiercigroch</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Sheikh</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Hulme</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use</article-title>
          <source>Subst Abuse Treat Prev Policy</source>
          <year>2020</year>
          <month>01</month>
          <day>13</day>
          <volume>15</volume>
          <issue>1</issue>
          <fpage>4</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-019-0250-1"/>
          </comment>
          <pub-id pub-id-type="doi">10.1186/s13011-019-0250-1</pub-id>
          <pub-id pub-id-type="medline">31931831</pub-id>
          <pub-id pub-id-type="pii">10.1186/s13011-019-0250-1</pub-id>
          <pub-id pub-id-type="pmcid">PMC6958640</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref35">
        <label>35</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kular</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Perry</surname>
              <given-names>BI</given-names>
            </name>
            <name name-style="western">
              <surname>Brown</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Gajwani</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Jasini</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Islam</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Birchwood</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Singh</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Stigma and access to care in first-episode psychosis</article-title>
          <source>Early Interv Psychiatry</source>
          <year>2019</year>
          <month>10</month>
          <volume>13</volume>
          <issue>5</issue>
          <fpage>1208</fpage>
          <lpage>1213</lpage>
          <pub-id pub-id-type="doi">10.1111/eip.12756</pub-id>
          <pub-id pub-id-type="medline">30411522</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref36">
        <label>36</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Priester</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>Browne</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Iachini</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Clone</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>DeHart</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Seay</surname>
              <given-names>KD</given-names>
            </name>
          </person-group>
          <article-title>Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review</article-title>
          <source>J Subst Abuse Treat</source>
          <year>2016</year>
          <month>02</month>
          <volume>61</volume>
          <fpage>47</fpage>
          <lpage>59</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/26531892"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jsat.2015.09.006</pub-id>
          <pub-id pub-id-type="medline">26531892</pub-id>
          <pub-id pub-id-type="pii">S0740-5472(15)00262-7</pub-id>
          <pub-id pub-id-type="pmcid">PMC4695242</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref37">
        <label>37</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lecomte</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Potvin</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Corbière</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Guay</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Samson</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Cloutier</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Francoeur</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Pennou</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Khazaal</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Mobile apps for mental health issues: meta-review of meta-analyses</article-title>
          <source>JMIR Mhealth Uhealth</source>
          <year>2020</year>
          <month>05</month>
          <day>29</day>
          <volume>8</volume>
          <issue>5</issue>
          <fpage>e17458</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://mhealth.jmir.org/2020/5/e17458/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/17458</pub-id>
          <pub-id pub-id-type="medline">32348289</pub-id>
          <pub-id pub-id-type="pii">v8i5e17458</pub-id>
          <pub-id pub-id-type="pmcid">PMC7293054</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref38">
        <label>38</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kumar</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Tully</surname>
              <given-names>LM</given-names>
            </name>
            <name name-style="western">
              <surname>Iosif</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Zakskorn</surname>
              <given-names>LN</given-names>
            </name>
            <name name-style="western">
              <surname>Nye</surname>
              <given-names>KE</given-names>
            </name>
            <name name-style="western">
              <surname>Zia</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Niendam</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>A mobile health platform for clinical monitoring in early psychosis: implementation in community-based outpatient early psychosis care</article-title>
          <source>JMIR Ment Health</source>
          <year>2018</year>
          <month>02</month>
          <day>27</day>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>e15</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://mental.jmir.org/2018/1/e15/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/mental.8551</pub-id>
          <pub-id pub-id-type="medline">29487044</pub-id>
          <pub-id pub-id-type="pii">v5i1e15</pub-id>
          <pub-id pub-id-type="pmcid">PMC5849797</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref39">
        <label>39</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Eisner</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Drake</surname>
              <given-names>RJ</given-names>
            </name>
            <name name-style="western">
              <surname>Berry</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Barrowclough</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Emsley</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Machin</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Bucci</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Development and long-term acceptability of ExPRESS, a mobile phone app to monitor basic symptoms and early signs of psychosis relapse</article-title>
          <source>JMIR Mhealth Uhealth</source>
          <year>2019</year>
          <month>03</month>
          <day>29</day>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>e11568</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://mhealth.jmir.org/2019/3/e11568/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/11568</pub-id>
          <pub-id pub-id-type="medline">30924789</pub-id>
          <pub-id pub-id-type="pii">v7i3e11568</pub-id>
          <pub-id pub-id-type="pmcid">PMC6460313</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref40">
        <label>40</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Niendam</surname>
              <given-names>TA</given-names>
            </name>
            <name name-style="western">
              <surname>Tully</surname>
              <given-names>LM</given-names>
            </name>
            <name name-style="western">
              <surname>Iosif</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Kumar</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Nye</surname>
              <given-names>KE</given-names>
            </name>
            <name name-style="western">
              <surname>Denton</surname>
              <given-names>JC</given-names>
            </name>
            <name name-style="western">
              <surname>Zakskorn</surname>
              <given-names>LN</given-names>
            </name>
            <name name-style="western">
              <surname>Fedechko</surname>
              <given-names>TL</given-names>
            </name>
            <name name-style="western">
              <surname>Pierce</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Enhancing early psychosis treatment using smartphone technology: a longitudinal feasibility and validity study</article-title>
          <source>J Psychiatr Res</source>
          <year>2018</year>
          <month>01</month>
          <volume>96</volume>
          <fpage>239</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jpsychires.2017.10.017</pub-id>
          <pub-id pub-id-type="medline">29126059</pub-id>
          <pub-id pub-id-type="pii">S0022-3956(17)30545-9</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref41">
        <label>41</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lim</surname>
              <given-names>MH</given-names>
            </name>
            <name name-style="western">
              <surname>Rodebaugh</surname>
              <given-names>TL</given-names>
            </name>
            <name name-style="western">
              <surname>Eres</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Long</surname>
              <given-names>KM</given-names>
            </name>
            <name name-style="western">
              <surname>Penn</surname>
              <given-names>DL</given-names>
            </name>
            <name name-style="western">
              <surname>Gleeson</surname>
              <given-names>JFM</given-names>
            </name>
          </person-group>
          <article-title>A pilot digital intervention targeting loneliness in youth mental health</article-title>
          <source>Front Psychiatry</source>
          <year>2019</year>
          <volume>10</volume>
          <fpage>604</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/31507469"/>
          </comment>
          <pub-id pub-id-type="doi">10.3389/fpsyt.2019.00604</pub-id>
          <pub-id pub-id-type="medline">31507469</pub-id>
          <pub-id pub-id-type="pmcid">PMC6716464</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref42">
        <label>42</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Vaessen</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Steinhart</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Batink</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Klippel</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Van Nierop</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Reininghaus</surname>
              <given-names>U</given-names>
            </name>
            <name name-style="western">
              <surname>Myin-Germeys</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>ACT in daily life in early psychosis: an ecological momentary intervention approach</article-title>
          <source>Psychosis</source>
          <year>2019</year>
          <month>03</month>
          <day>19</day>
          <volume>11</volume>
          <issue>2</issue>
          <fpage>93</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="doi">10.1080/17522439.2019.1578401</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref43">
        <label>43</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bonet</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Izquierdo</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Escartí</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Sancho</surname>
              <given-names>JV</given-names>
            </name>
            <name name-style="western">
              <surname>Arce</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Blanquer</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Sanjuan</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Use of mobile technologies in patients with psychosis: a systematic review</article-title>
          <source>Rev Psiquiatr Salud Ment</source>
          <year>2017</year>
          <volume>10</volume>
          <issue>3</issue>
          <fpage>168</fpage>
          <lpage>178</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://riunet.upv.es/handle/10251/103492"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.rpsm.2017.01.003</pub-id>
          <pub-id pub-id-type="medline">28258835</pub-id>
          <pub-id pub-id-type="pii">S1888-9891(17)30023-X</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref44">
        <label>44</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bonet</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Torous</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Arce</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Blanquer</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Sanjuan</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>ReMindCare app for early psychosis: pragmatic real world intervention and usability study</article-title>
          <source>JMIR Mhealth Uhealth</source>
          <year>2020</year>
          <month>11</month>
          <day>06</day>
          <volume>8</volume>
          <issue>11</issue>
          <fpage>e22997</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://mhealth.jmir.org/2020/11/e22997/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/22997</pub-id>
          <pub-id pub-id-type="medline">33155986</pub-id>
          <pub-id pub-id-type="pii">v8i11e22997</pub-id>
          <pub-id pub-id-type="pmcid">PMC7679204</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref45">
        <label>45</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Porras-Segovia</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>López-Moriñigo</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Álvarez</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Díaz-Oliván</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>González</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Baca-García</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Psychiatric relapse following a phone app intervention: a case report</article-title>
          <source>Psychiatry Res</source>
          <year>2021</year>
          <month>04</month>
          <volume>298</volume>
          <fpage>113766</fpage>
          <pub-id pub-id-type="doi">10.1016/j.psychres.2021.113766</pub-id>
          <pub-id pub-id-type="medline">33548692</pub-id>
          <pub-id pub-id-type="pii">S0165-1781(21)00063-9</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref46">
        <label>46</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lopez-Morinigo</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Barrigón</surname>
              <given-names>ML</given-names>
            </name>
            <name name-style="western">
              <surname>Porras-Segovia</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Ruiz-Ruano</surname>
              <given-names>VG</given-names>
            </name>
            <name name-style="western">
              <surname>Escribano Martínez</surname>
              <given-names>AS</given-names>
            </name>
            <name name-style="western">
              <surname>Escobedo-Aedo</surname>
              <given-names>PJ</given-names>
            </name>
            <name name-style="western">
              <surname>Sánchez Alonso</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Mata Iturralde</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Muñoz Lorenzo</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Artés-Rodríguez</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>David</surname>
              <given-names>AS</given-names>
            </name>
            <name name-style="western">
              <surname>Baca-García</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Use of ecological momentary assessment through a passive smartphone-based app (eB2) by patients with schizophrenia: acceptability study</article-title>
          <source>J Med Internet Res</source>
          <year>2021</year>
          <month>07</month>
          <day>26</day>
          <volume>23</volume>
          <issue>7</issue>
          <fpage>e26548</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2021/7/e26548/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/26548</pub-id>
          <pub-id pub-id-type="medline">34309576</pub-id>
          <pub-id pub-id-type="pii">v23i7e26548</pub-id>
          <pub-id pub-id-type="pmcid">PMC8367186</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref47">
        <label>47</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rizvi</surname>
              <given-names>SL</given-names>
            </name>
            <name name-style="western">
              <surname>Dimeff</surname>
              <given-names>LA</given-names>
            </name>
            <name name-style="western">
              <surname>Skutch</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Carroll</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Linehan</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>A pilot study of the DBT coach: an interactive mobile phone application for individuals with borderline personality disorder and substance use disorder</article-title>
          <source>Behav Ther</source>
          <year>2011</year>
          <month>12</month>
          <volume>42</volume>
          <issue>4</issue>
          <fpage>589</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="doi">10.1016/j.beth.2011.01.003</pub-id>
          <pub-id pub-id-type="medline">22035988</pub-id>
          <pub-id pub-id-type="pii">S0005-7894(11)00050-5</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref48">
        <label>48</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rotondi</surname>
              <given-names>AJ</given-names>
            </name>
            <name name-style="western">
              <surname>Spring</surname>
              <given-names>MR</given-names>
            </name>
            <name name-style="western">
              <surname>Hanusa</surname>
              <given-names>BH</given-names>
            </name>
            <name name-style="western">
              <surname>Eack</surname>
              <given-names>SM</given-names>
            </name>
            <name name-style="western">
              <surname>Haas</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Designing eHealth applications to reduce cognitive effort for persons with severe mental illness: page complexity, navigation simplicity, and comprehensibility</article-title>
          <source>JMIR Hum Factors</source>
          <year>2017</year>
          <month>01</month>
          <day>05</day>
          <volume>4</volume>
          <issue>1</issue>
          <fpage>e1</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://humanfactors.jmir.org/2017/1/e1/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/humanfactors.6221</pub-id>
          <pub-id pub-id-type="medline">28057610</pub-id>
          <pub-id pub-id-type="pii">v4i1e1</pub-id>
          <pub-id pub-id-type="pmcid">PMC5247620</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref49">
        <label>49</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Apóstolo</surname>
              <given-names>JLA</given-names>
            </name>
            <name name-style="western">
              <surname>Kolcaba</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>The effects of guided imagery on comfort, depression, anxiety, and stress of psychiatric inpatients with depressive disorders</article-title>
          <source>Arch Psychiatr Nurs</source>
          <year>2009</year>
          <month>12</month>
          <volume>23</volume>
          <issue>6</issue>
          <fpage>403</fpage>
          <lpage>411</lpage>
          <pub-id pub-id-type="doi">10.1016/j.apnu.2008.12.003</pub-id>
          <pub-id pub-id-type="medline">19926022</pub-id>
          <pub-id pub-id-type="pii">S0883-9417(08)00204-5</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref50">
        <label>50</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ascone</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Sundag</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Schlier</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Lincoln</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Feasibility and effects of a brief compassion-focused imagery intervention in psychotic patients with paranoid ideation: a randomized experimental pilot study</article-title>
          <source>Clin Psychol Psychother</source>
          <year>2017</year>
          <month>03</month>
          <volume>24</volume>
          <issue>2</issue>
          <fpage>348</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="doi">10.1002/cpp.2003</pub-id>
          <pub-id pub-id-type="medline">26888312</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref51">
        <label>51</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Jerath</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Crawford</surname>
              <given-names>MW</given-names>
            </name>
            <name name-style="western">
              <surname>Barnes</surname>
              <given-names>VA</given-names>
            </name>
            <name name-style="western">
              <surname>Harden</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Self-regulation of breathing as a primary treatment for anxiety</article-title>
          <source>Appl Psychophysiol Biofeedback</source>
          <year>2015</year>
          <month>06</month>
          <volume>40</volume>
          <issue>2</issue>
          <fpage>107</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="doi">10.1007/s10484-015-9279-8</pub-id>
          <pub-id pub-id-type="medline">25869930</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref52">
        <label>52</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Khoury</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Lecomte</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Comtois</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Nicole</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Third-wave strategies for emotion regulation in early psychosis: a pilot study</article-title>
          <source>Early Interv Psychiatry</source>
          <year>2015</year>
          <month>02</month>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>76</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1111/eip.12095</pub-id>
          <pub-id pub-id-type="medline">24112303</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref53">
        <label>53</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Koole</surname>
              <given-names>SL</given-names>
            </name>
            <name name-style="western">
              <surname>Tjew A Sin</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Schneider</surname>
              <given-names>IK</given-names>
            </name>
          </person-group>
          <article-title>Embodied terror management: interpersonal touch alleviates existential concerns among individuals with low self-esteem</article-title>
          <source>Psychol Sci</source>
          <year>2014</year>
          <month>01</month>
          <volume>25</volume>
          <issue>1</issue>
          <fpage>30</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="doi">10.1177/0956797613483478</pub-id>
          <pub-id pub-id-type="medline">24190907</pub-id>
          <pub-id pub-id-type="pii">0956797613483478</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref54">
        <label>54</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mittal</surname>
              <given-names>VA</given-names>
            </name>
            <name name-style="western">
              <surname>Vargas</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Osborne</surname>
              <given-names>KJ</given-names>
            </name>
            <name name-style="western">
              <surname>Dean</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Gupta</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Ristanovic</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Hooker</surname>
              <given-names>CI</given-names>
            </name>
            <name name-style="western">
              <surname>Shankman</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Exercise treatments for psychosis: a review</article-title>
          <source>Curr Treat Options Psychiatry</source>
          <year>2017</year>
          <month>06</month>
          <volume>4</volume>
          <issue>2</issue>
          <fpage>152</fpage>
          <lpage>166</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/29034144"/>
          </comment>
          <pub-id pub-id-type="doi">10.1007/s40501-017-0112-2</pub-id>
          <pub-id pub-id-type="medline">29034144</pub-id>
          <pub-id pub-id-type="pmcid">PMC5636011</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref55">
        <label>55</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Tang</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Tang</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Posner</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>Mindfulness meditation improves emotion regulation and reduces drug abuse</article-title>
          <source>Drug Alcohol Depend</source>
          <year>2016</year>
          <month>06</month>
          <day>01</day>
          <volume>163</volume>
          <issue>Suppl 1</issue>
          <fpage>S13</fpage>
          <lpage>S18</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S0376-8716(16)00117-4"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2015.11.041</pub-id>
          <pub-id pub-id-type="medline">27306725</pub-id>
          <pub-id pub-id-type="pii">S0376-8716(16)00117-4</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref56">
        <label>56</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Twamley</surname>
              <given-names>EW</given-names>
            </name>
            <name name-style="western">
              <surname>Vella</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Burton</surname>
              <given-names>CZ</given-names>
            </name>
            <name name-style="western">
              <surname>Heaton</surname>
              <given-names>RK</given-names>
            </name>
            <name name-style="western">
              <surname>Jeste</surname>
              <given-names>DV</given-names>
            </name>
          </person-group>
          <article-title>Compensatory cognitive training for psychosis: effects in a randomized controlled trial</article-title>
          <source>J Clin Psychiatry</source>
          <year>2012</year>
          <month>09</month>
          <volume>73</volume>
          <issue>9</issue>
          <fpage>1212</fpage>
          <lpage>1219</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/22939029"/>
          </comment>
          <pub-id pub-id-type="doi">10.4088/JCP.12m07686</pub-id>
          <pub-id pub-id-type="medline">22939029</pub-id>
          <pub-id pub-id-type="pmcid">PMC3593661</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref57">
        <label>57</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Vancampfort</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>De Hert</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Knapen</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Maurissen</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Raepsaet</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Deckx</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Remans</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Probst</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Effects of progressive muscle relaxation on state anxiety and subjective well-being in people with schizophrenia: a randomized controlled trial</article-title>
          <source>Clin Rehabil</source>
          <year>2011</year>
          <month>06</month>
          <volume>25</volume>
          <issue>6</issue>
          <fpage>567</fpage>
          <lpage>575</lpage>
          <pub-id pub-id-type="doi">10.1177/0269215510395633</pub-id>
          <pub-id pub-id-type="medline">21402653</pub-id>
          <pub-id pub-id-type="pii">0269215510395633</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref58">
        <label>58</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Spidel</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Lecomte</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Kealy</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Daigneault</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Acceptance and commitment therapy for psychosis and trauma: improvement in psychiatric symptoms, emotion regulation, and treatment compliance following a brief group intervention</article-title>
          <source>Psychol Psychother</source>
          <year>2018</year>
          <month>06</month>
          <volume>91</volume>
          <issue>2</issue>
          <fpage>248</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1111/papt.12159</pub-id>
          <pub-id pub-id-type="medline">28976056</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref59">
        <label>59</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Stotts</surname>
              <given-names>AL</given-names>
            </name>
            <name name-style="western">
              <surname>Northrup</surname>
              <given-names>TF</given-names>
            </name>
          </person-group>
          <article-title>The promise of third-wave behavioral therapies in the treatment of substance use disorders</article-title>
          <source>Curr Opin Psychol</source>
          <year>2015</year>
          <month>04</month>
          <day>01</day>
          <volume>2</volume>
          <fpage>75</fpage>
          <lpage>81</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/26693170"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.copsyc.2014.12.028</pub-id>
          <pub-id pub-id-type="medline">26693170</pub-id>
          <pub-id pub-id-type="pmcid">PMC4674809</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref60">
        <label>60</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ben-Zeev</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Brenner</surname>
              <given-names>CJ</given-names>
            </name>
            <name name-style="western">
              <surname>Begale</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Duffecy</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Mohr</surname>
              <given-names>DC</given-names>
            </name>
            <name name-style="western">
              <surname>Mueser</surname>
              <given-names>KT</given-names>
            </name>
          </person-group>
          <article-title>Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia</article-title>
          <source>Schizophr Bull</source>
          <year>2014</year>
          <month>11</month>
          <volume>40</volume>
          <issue>6</issue>
          <fpage>1244</fpage>
          <lpage>1253</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/24609454"/>
          </comment>
          <pub-id pub-id-type="doi">10.1093/schbul/sbu033</pub-id>
          <pub-id pub-id-type="medline">24609454</pub-id>
          <pub-id pub-id-type="pii">sbu033</pub-id>
          <pub-id pub-id-type="pmcid">PMC4193714</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref61">
        <label>61</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Jermann</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Van der Linden</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>d'Acremont</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Zermatten</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cognitive Emotion Regulation Questionnaire (CERQ)</article-title>
          <source>Eur J Psychol Assess</source>
          <year>2006</year>
          <month>01</month>
          <volume>22</volume>
          <issue>2</issue>
          <fpage>126</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="doi">10.1027/1015-5759.22.2.126</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref62">
        <label>62</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lukoff</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Nuechterlein</surname>
              <given-names>KH</given-names>
            </name>
            <name name-style="western">
              <surname>Ventura</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Manual for the expanded brief psychiatric rating scale</article-title>
          <source>Schizophr Bull</source>
          <year>1986</year>
          <volume>12</volume>
          <fpage>594</fpage>
          <lpage>602</lpage>
          <pub-id pub-id-type="doi">10.1007/springerreference_184605</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref63">
        <label>63</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Garnefski</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Kraaij</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>The Cognitive Emotion Regulation Questionnaire</article-title>
          <source>Eur J Psychol Assess</source>
          <year>2007</year>
          <month>01</month>
          <volume>23</volume>
          <issue>3</issue>
          <fpage>141</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="doi">10.1027/1015-5759.23.3.141</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref64">
        <label>64</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sobell</surname>
              <given-names>MB</given-names>
            </name>
            <name name-style="western">
              <surname>Maisto</surname>
              <given-names>SA</given-names>
            </name>
            <name name-style="western">
              <surname>Sobell</surname>
              <given-names>LC</given-names>
            </name>
            <name name-style="western">
              <surname>Cooper</surname>
              <given-names>AM</given-names>
            </name>
            <name name-style="western">
              <surname>Sanders</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <source>Developing a prototype for evaluating alcohol treatment effectiveness</source>
          <year>1980</year>
          <publisher-loc>New York, NY</publisher-loc>
          <publisher-name>Pergamon Press</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref65">
        <label>65</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Litten</surname>
              <given-names>RZ</given-names>
            </name>
            <name name-style="western">
              <surname>Allen</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <source>Measuring alcohol consumption: psychosocial and biological methods</source>
          <year>1992</year>
          <publisher-loc>Totowa, NJ</publisher-loc>
          <publisher-name>Humana Press</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref66">
        <label>66</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Humeniuk</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Ali</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Babor</surname>
              <given-names>TF</given-names>
            </name>
            <name name-style="western">
              <surname>Farrell</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Formigoni</surname>
              <given-names>ML</given-names>
            </name>
            <name name-style="western">
              <surname>Jittiwutikarn</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>de Lacerda</surname>
              <given-names>RB</given-names>
            </name>
            <name name-style="western">
              <surname>Ling</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Marsden</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Monteiro</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Nhiwatiwa</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Pal</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Poznyak</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Simon</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST)</article-title>
          <source>Addiction</source>
          <year>2008</year>
          <month>06</month>
          <volume>103</volume>
          <issue>6</issue>
          <fpage>1039</fpage>
          <lpage>1047</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1360-0443.2007.02114.x</pub-id>
          <pub-id pub-id-type="medline">18373724</pub-id>
          <pub-id pub-id-type="pii">ADD2114</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref67">
        <label>67</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Khan</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Chatton</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Nallet</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Broers</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Thorens</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Achab-Arigo</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Poznyak</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Fleischmann</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Khazaal</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Zullino</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Validation of the French version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)</article-title>
          <source>Eur Addict Res</source>
          <year>2011</year>
          <volume>17</volume>
          <issue>4</issue>
          <fpage>190</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="doi">10.1159/000326073</pub-id>
          <pub-id pub-id-type="medline">21494047</pub-id>
          <pub-id pub-id-type="pii">000326073</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref68">
        <label>68</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Albertella</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Gibson</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Rooke</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Norberg</surname>
              <given-names>MM</given-names>
            </name>
            <name name-style="western">
              <surname>Copeland</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A smartphone app intervention for adult cannabis users wanting to quit or reduce their use: a pilot evaluation</article-title>
          <source>J Cannabis Res</source>
          <year>2019</year>
          <month>08</month>
          <day>16</day>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-019-0009-6"/>
          </comment>
          <pub-id pub-id-type="doi">10.1186/s42238-019-0009-6</pub-id>
          <pub-id pub-id-type="medline">33526112</pub-id>
          <pub-id pub-id-type="pii">10.1186/s42238-019-0009-6</pub-id>
          <pub-id pub-id-type="pmcid">PMC7819295</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref69">
        <label>69</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hides</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Baker</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Norberg</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Copeland</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Quinn</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Walter</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Leung</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Stoyanov</surname>
              <given-names>SR</given-names>
            </name>
            <name name-style="western">
              <surname>Kavanagh</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>A web-based program for cannabis use and psychotic experiences in young people (Keep It Real): protocol for a randomized controlled trial</article-title>
          <source>JMIR Res Protoc</source>
          <year>2020</year>
          <month>07</month>
          <day>29</day>
          <volume>9</volume>
          <issue>7</issue>
          <fpage>e15803</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.researchprotocols.org/2020/7/e15803/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/15803</pub-id>
          <pub-id pub-id-type="medline">32723727</pub-id>
          <pub-id pub-id-type="pii">v9i7e15803</pub-id>
          <pub-id pub-id-type="pmcid">PMC7424487</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref70">
        <label>70</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Tatar</surname>
              <given-names>O</given-names>
            </name>
            <name name-style="western">
              <surname>Abdel-Baki</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Wittevrongel</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Lecomte</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Copeland</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Lachance-Touchette</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Coronado-Montoya</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Côté</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Crockford</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Dubreucq</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>L'Heureux</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Ouellet-Plamondon</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Roy</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Tibbo</surname>
              <given-names>PG</given-names>
            </name>
            <name name-style="western">
              <surname>Villeneuve</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Jutras-Aswad</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Reducing cannabis use in young adults with psychosis using iCanChange, a mobile health app: protocol for a pilot randomized controlled trial (ReCAP-iCC)</article-title>
          <source>JMIR Res Protoc</source>
          <year>2022</year>
          <month>11</month>
          <day>25</day>
          <volume>11</volume>
          <issue>11</issue>
          <fpage>e40817</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.researchprotocols.org/2022/11/e40817/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/40817</pub-id>
          <pub-id pub-id-type="medline">36427227</pub-id>
          <pub-id pub-id-type="pii">v11i11e40817</pub-id>
          <pub-id pub-id-type="pmcid">PMC9736767</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
